Insider trades
Poon Christine A
Poon Christine A made 0 buys and 6 sales on the open market in the last 12 months at Regeneron Pharmaceuticals, Inc., Neurocrine Biosciences, Inc. and Prudential Financial, Inc. Each trade with the role, price and filing.
Insider trades
Where they report
| Company | Role | Holding after | Latest trade |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Director | 5,219 | Nov 2, 2026 |
| Neurocrine Biosciences, Inc. NASDAQ:NBIX | Director | 4,753 | May 21, 2026 |
| Prudential Financial, Inc. NYSE:PRU | Director | 11,583 | May 12, 2026 |
Open-market trades, newest first
| Company | Date | Trade | Shares | Price | Value | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Nov 2, 2026 | Sale | 218 | US$966.74 | US$211K | 12,831 | Nov 4, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Nov 2, 2026 | Sale | 772 | US$967.38 | US$747K | 12,059 | Nov 4, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Nov 2, 2026 | Sale | 2,499 | US$968.58 | US$2.42M | 9,560 | Nov 4, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Nov 2, 2026 | Sale | 3,203 | US$969.50 | US$3.11M | 6,357 | Nov 4, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Nov 2, 2026 | Sale | 937 | US$970.51 | US$909K | 5,420 | Nov 4, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | Nov 2, 2026 | Sale | 201 | US$971.31 | US$195K | 5,219 | Nov 4, 2026 |